Company registration number: 04906693
Charity registration number.. 1102413
Cancer Active
IA company limited by guarantee)
Annual Report and Financial Statements
for the Year Ended 31 March 2025

Cancer Active
Contents
Reference and Administrative Details
Trustee, Report
2to6
Independent Examiner'5 Report
Statement of Financial Activities
8t09
Balance Sheet
Iotoll
Notes to the Financial statements
12to18

Cancer Active
Reference and Administrative Details
Directors and Trustees
S M Thomas
L Brooks
Secretary
S M Thomas
Charity Reglstration Number
1102413
Company Registration Numbey
1)4906693
The charity is incorporated in England.
Operations Address
Apple Tree Cottage
Hay Lane
Fulmer
SL3 6HJ
Henge Barn
Pury Hill Busines5 Park
Alderton Road
Towcester
Northants
NN12 7LS
Thompson5 MK Ltd
Henge Barn
Pury Hill Business Park
Alderton Road
Towcester
Northants
NN12 7LS
Registered office Address
Independent Examiner
HSBC
2Walton Road
AYLESBURY
Bucks
HP217SS
Bankers
Page I

Cancer Active
Trustees, Report
The trustee, who are directors for the purposes of company law, present the annual report together with the
financial statements of the charitable company for the year ended 31 March 2025.
Objectlves and acttvities
Object5 ond aims
The company is a charity and exists to provide information from all published scientific sources around the world
so that people wanting to beat cancer can make more informed choices.
The objettives of the charity are..
• The relief of sickness of persons suffering from cancer by the provision of support and information.
The advancement of education of the public by funding for research into cancer and the dissemination of the
useful results of such research and by providing information and advice.
CANCERactive aim5 to provide information, notjust on orthodox medicine.
The charity is not supported by any major corporations (such as pharmaceutital companies) and so has been
unable to fund its own research, which is extremely costly. However, it successfully fulfills it5 Objectives by
focusing on providing various types of information including the research of others from around the world. It
also provides support to cancer patients. The charity does not provide advice or counselling as the Trustees feel
that the resources of the charity are too limited and, furthermore, they feel this might break the 1939 Cancer
Advertising Act.
To date the charity has pioneered a free and unique magazine, icon Ilntegrated Cèncer and Oncology New51,
which 15 available in over 400 hospitals, cancer clinics and libraries across Britain. The magazine is very well
received by patients and hospital staff. Oncology professors from both sides of the Atlantic contribute.
The charity has a large and informative web51te Iwww.canceractive.coml which provides extensive information
on all types of cancer and cancer prevention. The website a150 provides up to date reports on research and
clinical trials from around the world in its research centre 'Cancer Watch,. A Medical Board was set up in the
year 2011/2 and this includes professors of oncology, integrative doctors and experts in the field of
complementary therapv.
Publicbenefit
The Trustees have referred to the Charity Commission's general guidance on public benefit when reviewing the
objectives and when planning future activities.
The trustee confirm that they have complied with the requirements of section 17 of the Charities Act 2011 to
have due regard to the public benefit guidance published by the Charity Commission for England and Wales.
Page 2

Cancer Active
Trustees, Report
Achievements and performance
Turning 'Survival' into Transition,
The Pandemic hit everybody in the pocket. It crippled small businesses and hurt individuals and families. The
new Labour Government doesn't appear to be helping much, with actions against Winter Fuel allowance and
plans for heightened taxes. It's hard to predict the future but we believe people with cancer will have even less
money next year.
The traditional cancer patient has been biased to the over 60 age group, but this has been getting younger over
the past decade or two. The pandemic seems to have accelerated thi5. The Chief exec of Pfizer, Albert Bourla,
talked about Turbo Cancer in his Oxford Univer51ty interview saying that Pfizer were buying companies to
strengthen their cancer resource5, and that they felt a third of all families would see Turbo cancer. Yale Medicine
then produced research showing cancer case5 were being seen in even younger people and that, for example,
young women had added problems such as looking after young children.
We are Seeing all this at CANCERactive too. More people with cancer, younger people with cancer, and more
people struggling to make ends meet.
When the Pandemic hit, we were safely positioned. We have very low running costs. It was however sad to see
hospltals not wanting our flagship magazine (the idea of our late founder Catherine Woollams) because touching
it might spread Covid 111 but Chris Woollams was persuaded to leave his comfort lone and turn into an
interviewer. He built the CANCERartive Sunday Show and raised money for us by interviewing oncology
Professors such as Robert Thomas and Karol Sikora, Doctors such as Thomas Lodi, people with cancer expertise
such as Holistic Dentist Elmar Jung, Chinese Medicine expert George Cooper and Natural Progesterone expert
Judy Evan5. He then interviewed a host of former patients who credit him with beating their cancer - covering
Lung, Colorectal, Breast, Prostate and many more cancers. We levied a small charge, or people became
community members. We survived.
We are also helped by donor5 who have raised money from running the marathon and climbing mountains along
with many regular supporters of CANCERactive.
Page 3

Cancer Active
Trustees, Report
Financlal revlew
The net outgoing resources for the period amounted to £17,793. At 31 March 2025 the charity had a fund
Surplus of £89,022, consisting of general reserves and no restricted fund5.
More than this we were interested in how we were seen by the public, so we went to see what Al says about
CANCERattive. This from 8RAVE:
"CANCERactive is a well-established UK-bosed patient infvrmotion charity that provides detoiled. referenced
guidunce on complementary and integrative approaches to cancer care. Its article5frequently include multiple
references to scientific studies, and it has been a pioneer in making evidence-ba58d con7plernentory Ct7ncer
strategies accessible to the public. The organization wasfounded by a cancer survivor and ht75 built a
reputationfor thorough research and clear communication.
It 15 a credible, well-referenced patient education resource whereas. some h05Pltal websltes or institutional
sources may present subjective or poorly referenced content, ond inconsistencies sourcing stondords across
platform5 ure a vt71id concern-
Policy on resekves
The Trustees have established a policy whereby the unrestricted funds not committed or invested in tangible
fixed a55et51"the free reserves"I held by the charity should be between 3 to 6 months of the resources
expended. At this level the Trustee5 believe that they would be able to continue the current activities of the
charity in the event of a significant drop in funding. It would obviously be necessary to consider how funding
would be replaced or activities changed.
Plans for future perlods
Aim5 andkey objective5forfuture periods
It is our aim to help our patients as a friendly and trusted resource. We do that well because we understand
them. Everyone working with CANCERactive has been touched by cancer - we are proud of this.
We aim to build a strong global community, to bring them videos that help, videos they can trust, to back up
the articles on the website that often come with 10 or more references. We maintain our strategy of helping
people touched by cancer to increase their personal odds of survival, but we will be adding to the website with
stronger social media content, videos and podcasts.
We may also merge Chris, other Websites IHealth Watch and Rainbow Diet into CANCERactive, and we may
even have an annual icon magazine. We're in transition, but we have lots of great ideas about what that means
for Britain's number one Integrative and Complementary cancer charity.
Page 4

Cancer Active
Trustees, Report
Trustees and offlcers
The trustee5 and officer5 serving during the year and since the year-end were as follows:
Trustee..
S M Thomas
L Brooks
Secretary:
S M Thomas
Structure, governance and management
Organisotionalstructure
The charity is constituted as a company limited by guarantee. Trustees are recruited by personal invitation and
recommendation and are entirely voluntary receiving no remuneration.
Financial instruments
Finoncial risk management objectives andpolicies
The Trustees have conducted their own review of the major risks to which the charity is exposed, and systems
have been established to mitigate those risks.
Significant external risks to funding have led to the development of a strategic plan, which will allow for
diversification of funding and activities.
Internal risk5 are minimised by having authorisation for all transactions and projects and having procedures in
place for computer failure. Internal reviews ensure that a consistently high standard of information 15 given, and
the social policies are fully compliant with current legislation. These procedures are periodically reviewed to
ensure they still meet the needs of the charity.
Page 5

Cancer Active
Trustees. Report
Statement of Trustee, Responsibilities
The trustee (who are also the directors of Cancer Active for the purposes of company lawl are responsible for
preparing the trustee, report and the financial statements in accordance with the United Kingdom Accounting
Standards (United Kingdom Generally Accepted Accounting Practice) and applicable law and regulation5.
Company law requires the trustee to prepare financial statements for each financial year. Under company law
the trustee rnust not approve the financial statements unless they are satisfied that they give a true and fair
view of the state of affairs of the charitable company and of its incoming resources and application of resource5.
including its income and expenditure, for that period. In preparing these financial statements, the trustee are
required to..
Select suitable accounting policies and apply them consistently,.
observe the methods and principles in thè Charities SORP,.
make judgements and estimates that are reasonable and prudent,.
State whether applicable UK Accotjnting Standard5 have been followed, subject to any material departures
disclosed and explained in the financial st3tement5,' and
prepare the financial statements on the going concern basis unless it 15 inappropriate to presume that the
charitable company will continue in business.
The trustees are responsible for keeping adequate accounting record5 that are sufficient to show and explain
the charitable company's transactions and disclose with reasonable accuracy at any time the financial position
of the charitable company and enable them to ensure that the financial statements comply with the Companies
Act 2006. They are also responsible for safeguarding the assets of the charitable company and hence for taking
reasonable Steps for the prevention and detection of fraud and other irregularitie5.
The an
ual report was approved by the trustee of the charity on
and signed on its behalf bv:
L Broo
Trus
Page 6

Cancer Active
Independent Examiner's Report to the trustees of Cancer Active {"the Company"}
I report to the charity trustee on my examination of the accounts of the Company for the year ended 31, March
2025.
Responsibilities and basls of report
As the charity's trustee of the Company land also Its director5 for the purposes of company lawl you are
responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006
I'the 2006 Act'l.
Having satisfied myself that the accounts of Cancer Active are not required to be audited under Part 16 of the
2006 Act and are eligible for independent examination, I report in respect of my examination of your charit¢5
accounts as carried out undèr section 145 of the uharities Ar.t 2011 I'the 2011 Act'l. In carryillg out my
examination I have followed the Direction5 given by the Charity Commission under section 14515llbl of the 2011
Act.
Independent èJ(amlnerfs statement
I have completed my examination. I confirm that no matters have come to my attention in connection with the
examination giving me cause to believe..
l. accounting records were not kept in respect of Cancer Active as required by section 386 of the 2006 Act,.
or
2. the accounts do not accord with those records; or
3. the accounts do not comply with the accounting requirements of section 396 of the 2006 Act other than
any requirement that the accounts give a 'true and fair view, which is not a matter considered as Pdrt of
an independent examination- or
4. the accounts have not been prepa red in accorda nce with the methods and principle5 of the Statement of
flecommended Practice for accounting and reporting by charities lapplicable to charities preparing their
accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland
{FRS 10211.
I have no concerns and have come acr055 no other matters in connection with the examination to which
attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.
Mr
ex Beattie MAAT FCA
Thompsons MK Ltd
Henge Barn, Pury Hill Business Park
Alderton Road
Towcester
Northants
NN12 7LS
Date..
Page 7

Cancer Active
Statement of Financial Activities for the Year Ended 31 March 2025
(Including Income and Expenditure Account and Statement of Total Recognised Gains and
Losses}
Unrestricted
funds
Restricted
funds
Total
2025
Note
Income and Endowmentsfrom:
Donations
79,794
1,716
1,500
79,794
1,716
1.500
Other trading activities
Investment income
Total income
83,010
83,010
EJ(penditure on:
Raising funds
Charitable activities
127,6431
173,1601
127,6431
(73,1601
Total expenditure
1100,8031
1100,8031
Net income
117,7931
117,7931
Net movement in funds
117,7931
117,7931
Reconciliatlon of funds
Total funds brought forward
106,815
106,815
Total funds carried forward
89,022
89,022
The notes on pages 12 to 18 form an integral part of these financial statements.
Page 8

Cancer Active
Statement of Financial Activities for the Year Ended 31 March 2025
{Including Income and Expenditure Account and Statement of Total Recognised Gains and
Losses)
Comparative data fortheyear Ended 31 March 2024
Unrestricted
funds
Restricted
funds
Total
2024
Note
Income and Endowments from:
Donations
other trading activities
122,748
1,963
122,748
1,963
1,330
126,041
1,330
126,041
Investment income
Total income
Expenditure on:
Raising funds
Charitable activities
{13.7531
161,0591
113,7531
161,0591
174,8121
174,8121
Total expenditure
Net income
51,229
51,229
Net movement in fund5
Reconciliation of funds
Total funds brought forward
Total fund5 carried forward
51,229
51,229
55,586
55,586
106,815
106,815
All of the charity's activities derive from continuing operations during the above two periods.
The breakdown of funds is shown in note 9.
The note5 on pages 12 to 18 form an integral part of these financial statements.
Page 9

Cancer Active
(Registration number: 04906693)
Balance Sheet as at 31 March 2025
2025
2024
Note
Flxed assets
Tangible assets
1,277
810
Current assets
Stocks
Debtors
Cash at bank and in hand
7,500
1,518
98,349
1,397
81,341
90,738
107,367
Credltors: Amounts fallin8 due within one year
Net current assets
Net assets
106
Funds ofthe charity:
Restricted income funds
Restricted funds
Unrestricted income funds
Unrestricted fund5
106815
Total funds
02
For the financial year ending 31 March 2025, the cha rity was entitled to exemption from audit under section
477 of the Companies Act 2006 relating to small companie5.
Directors, responsibilities-
The members have not required the charity to obtain an audit of its accounts for the year in question in
accordance with sertion 476,. and
The directors acknowledge their responsibilities for complying with the requirements of the Act with
respect to accounting records and the preparation of accounts.
The notes on pages 12 to 18 form an integral part of these financial statements.
Page 10

Cancer Active
(Registration number: 04906693)
Balance Sheet as at 31 March 2025
These financial statements have been prepared in accordance with the special provisions relating to
companie5 subject to the small companie5 regime within Part 15 of the Companies Act 2006.
The financial statements were approved and authorised for issue by the board and signed on its behalf on..
Date
L Brog
Trustee
The notes on pages 12 to 18 *orm an integral part of these financial statements.
Page 11

Cancer Active
Notes to the Financial Statements for the Year Ended 31 March 2025
I Charity status
The charity is limited by guarantee, incorporated in England, and consequently does not have share capital. Each
of the trustee is liable to contribute an amount not exceeding £10 towards the assets of the charity in the event
of liquidation.
CANCERactive was incorporated on 22 September 2003 as a company limited by guarantee and registered as a
charity on l March 2004.
The company was created under a Memorandum of A5SOClation, which established the objects and power5 of
the Charitable Company and 15 governed under its Articles of Association. Under those Articles the Board of
Trustees are elected at the AGM to serve a period of 3 years, subject to ratification at each AGM.
The address of its registered office is..
Henge Barn
Pury Hill Business Park
Alderton Road
Towcester
NN12 7LS
The principal place of business is..
Apple Tree Cottage
Hay Lane
Fulmer
SL3 6HJ
2 Accounting policies
Summary of signlficant accounting policies and key accounting estimates
The principal accounting policies applied in the preparation of these financial statements are set out below.
These policie5 have been consistently applied to all the year5 presented, unless otherwise stated.
Statement of compliance
The financial statements have been prepared in accordance with Accounting and Reporting by Charities..
Statement of Recommended Practice (applicable to charities preparing their accounts in accordance with the
Financial Reporting Standard applicable in the UK and Repu blic of Ireland IFRS 10211 (issued in October 20191
(Charities SORP IFRS 10211, the Financial Reporting Standard applicable in the UK and Republic of Ireland IFRS
1021 and the Companies Act 2006.
Basis of preparation
Cancer Active meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially
recogni5ed at historical cost or transaction value unless otherwise stated in the relevant accounting policy
notes.
Going concern
The trustees consider that there are no material uncertainties about the charitV'5 ability to continue as a going
concern nor any significant area5 of uncertainty that affect the carrying value of assets held by the charity.
Page 12

Cancer Active
Notes to the Financial Statements for the Year Ended 31 March 2025
Income and endowments
All income is recognised once the charity has entitlement to the income, it 15 probable that the income wi￿1 be
received and the amount of the income receivable can be measured reliably.
Donations and legacies
Donations are recognised when the charity has been notified in writing of both the amount and settlement
date. In the event that a donation is subject to conditions that require a level of performance by the charity
before the charity is entitled to the funds, the income is deferred and not recogni5ed until either those
conditions are fully met, or the fulfilment of those conditions is wholly within the control of the charity and it is
probable that these condition5 will be fulfilled in the reporting period.
Expenditure
All expenditure is recognised once there is a legal or constructive obligation to that expenditure, it is probable
settlement is required and the amount can be measured reliably. All costs are allocated to the applicable
expenditure heading that aggregate similar CDStS to that category. Where costs cannot be directly attributed to
particular headings they have been allocated on a basis con515tent with the use of resources, Wlth central staff
costs allocated on the basis of time spent, and depreciation charges allocated on the portion of the asset's use.
Other support costs are allocated based on the spread of staff costs.
Roislngfvnd5
These are costs incurred in attracting voluntary income, the management of investment5 and those incurred in
trading activities that raise funds.
Support costs
Support costs include central functions and have been allocated to activity cost categories on a basis
consistent with the use of resources, for example, allocating property Costs by floor areas, or per capita, staff
Costs by the time spent and other costs by their usage.
Governance costs
These include the costs attributable to the charity's compliance with constitutional and statutory
requirements, including audit, strategic management and trustee's meetings and reimbursed expenses.
Taxation
The charity is considered to pa55 the tests Set out in Paragraph I Schedule 6 of the Finance Act 2010 and
therefore it meets the definition of a charitable company for UK corporation tax purposes. Accordingly, the
charity 15 Potentially exempt from taxation in respect of income or capital gains received within categories
covered by Chapter 3 Part 11 of the Corporation Tax Act 2010 or Section 256 of the Taxation of Chargeable
Gains Act 1992, to the extent that such income or gains are applied exclusively to charitable purposes.
Tangible fixed assets
Ind ividual fixed assets costing £100.00 or more are initially recorded at cost, le55 any subsequent accumulated
depreciation and subsequent accumulated impairment losses.
Page 13

Cancer Active
Notes to the Financial Statements for the Year Ended 31 March 2025
Cash and cash equivalents
Cash and cash equivalents comprise cash on hand and call dep051ts. and other short-term highly liquid
investments that are readily convertible to a known amount of cash and are subject to ar> insignificant risk of
change in value.
Trade creditor5
Trade creditors are obligation5 to pay for good5 or services that have been acquired in the ordinary course of
business from suppliers. Account5 payable are classified as current liabilities if the charity does not have an
unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve
months after the reporting date. If there is an unconditional right to defer settlernent for at least twelve
months after the reporting date. they are presented as non-current liabilities.
Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost
using the effective interest method.
Fund strurture
Unrestricted income funds are general funds that are available for use at the trustee discretion in furtherance
of the objectives of the charity.
Restricted income funds are those donated for use in a particular area or for Specific purposes, the use of
which is restricted to that area or purpose.
Financial instruments
Classifi¢otion
Financial assets and financial liabilitie5 are recognised when the charity becomes a party to the contractual
provi5ion5 of the instrument.
Financial liabilities and equity instruments are classified according to the substance of the contractual
arrangements entered into. An equity instrument is any contract that evidences a residual interest in the
assets of the charity after deducting all of its liabilities.
Page 14

Cancer Active
Notes to the Financial Statements for the Year Ended 31 March 2025
Recognition andmeusurement
All financial assets and liabilities are initially measured at transaction price (including transaction cost51, except
for those financial assets classified as at fair value through profit or loss, which are initially measured at fair value
Iwhich is normally the transaction price excluding transaction costs), unless the arrangement constitutes a
financing transaction. If an arrangement constitLttes a financing transaction, the financial a55et or financial
liability 15 measured at the present value of the future payments discounted at a market rate of interest for a
similar debt instrument.
Financial assets and liabilities are only offset in the statement of financial position when, and only when there
exists a legally enforceable right to set off the recognised amounts and the charity intends either t9 Settle on a
net basis, or to realise the asset and settle the liability simultaneously.
Financial assets are derecognised when and only when al the contractual right5 to the cash flow5 from the
financial asset expire or are settled, bl the charity transfer5 to another party substantially all of the risks and
rewards of ownership of the financial asset, or cl the charity, despite having retained some, but not all, significant
risks and rewards of ownership, has transferred control of the asset to another partv.
Financial liabilities are derecognised only when the obligation specified in the contract is dischar8ed, cancelled
or expires.
3 Income from other trading activities
Unrestrirted
funds
General
Total
funds
Total
2024
Trading income:
Magazine and book 5ale5
Sunday shows
836
836
743
880
880
4 Expenditure on raisin8 funds
al Costs of generating donation5 and legacies
Unrestricted
funds
General
Total
funds
Website
Fund raising events
10,206
1,615
10,206
1,615
Total for 2025
Total for 2024
Page 15

Cancer Active
Notes to the Financial Statements for the Year Ended 31 March 2025
b} Costs of trading artlvities
Unrestricted
funds
General
Restricted
funds
Total
funds
Note
Magazine and book production
15,822
15,822
Total for 2025
Total lor 2024
5 Expenditure on charitable actlvities
Unre5trlcted
funds
General
Total
2025
Total
2024
Independent examiner fees
Consultancy
Depreciation
Other governance costs
Administration
1,200
16,200
1,238
19,632
1,200
16,200
1,238
19,632
1,200
16,657
270
17,629
7a
Page 16

Cancer Active
Notes to the Financial Statements for the Year Ended 31 March 2025
6 Tangible fixed assets
Furniture and
equipment
Total
Cost
At l April 2024
At 31 March 2025
6,475
6,475
Depreciation
At l April 2024
Charge for the year
3,960
3,960
At 31 March 2025
5,198
5,198
Net bookvalue
At31 March 2025
At 31 March 2024
7 Debtors
2025
2024
Prepayment5
VAT refundable
549
517
848
I,ooi
8 Creditors: amounts falling due within one year
2025
2024
Trade creditors
Accruals
1,793
1,200
162
1,200
Page 17

Cancer Active
Notes to the Financial Statements for the Year Ended 31 March 2025
9 Fund5
Balance at I
Aprll 2024
Incoming
resources
Resources
expended
Balance at 31
March 2025
Unrestrbrted funds
General
106,815
83,010
1100,8031
89,022
Restricted funds
03
Total funds
106 815
Balance at I
April 2023
Incoming
resources
Resources
expended
Balance at 31
March 2024
Unrestrirted funds
General
55,586
126.041
174,8121
106,815
Re5trlcted funds
Total funds
Page 18